Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At.
The cyclotron alpha beam production of 211At and of the contaminant 210At related to beam energy were studied. Radiochemical purification of 211At from the other main contaminant, 210Po, by an extraction procedure was also evaluated. To avoid impurities 28MeV has previously been considered as a maximum beam energy, but by using instead 29.1 MeV as a limit a large increase in EOB yield and sufficient radiochemical purity of extracted 211At were obtained. More cyclotrons could thereby deliver quantities useful for clinical cancer trials.
Department of Chemistry, University of Oslo, Norway.
G
G
Henriksen
S
S
Messelt
E
E
Olsen
R H
RH
Larsen
D001246:Astatine; D001729:Bismuth; D017357:Cyclotrons; D011059:Polonium; D011868:Radioisotopes; D019275:Radiopharmaceuticals / Q000138:chemical synthesis*
D011868:Radioisotopes; D019275:Radiopharmaceuticals; D011059:Polonium; D001729:Bismuth; D001246:Astatine